{ "items": [ "\n\n
\n \n 3 October 2023\n \n
\n\n \n\n \n\n \n \n \n \n NDM\n \n \n\n \n\n\n
\n \n\n \n \n \nIn a study, recently published in the Cell, an international team of scientists, including CAMS Oxford Institute (COI) group leaders Professor Graham Ogg and Dr Yi-Ling Chen, has developed a method for simultaneously detecting thousands of lipid molecules that are displayed to T cells in the human immune system.
\n \n\n\n \n 1 September 2023\n \n
\n\n \n\n \n\n \n \n \n \n NDM\n \n \n \n \n NDMRB\n \n \n \n \n WIMM\n \n \n\n \n\n\n
\n \n\n \n \n \nWith effect from 1st May 2023, Professor Tao Dong, has been appointed the Brigitte (Ita) Askonas Professor of Translational Immunology.
\n \n\n\n \n 3 July 2023\n \n
\n\n \n\n \n\n \n \n \n \n Kennedy\n \n \n\n \n\n\n
\n \n\n \n \n \nA new type of macrophages recently identified in atherosclerotic lesions could provide a missing link in understanding the inflammatory origins of the common yet fatal condition.
\n \n\n\n \n 13 June 2023\n \n
\n\n \n\n \n\n \n \n \n \n NDM\n \n \n\n \n\n\n
\n \n\n \n \n \nThe results of this observational study can help clinicians to estimate prognosis for patients diagnosed with breast cancer today.
\n \n\n\n \n 13 June 2023\n \n
\n\n \n\n \n\n \n \n \n \n DPAG\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor David Paterson, in collaboration with the UCLA\u2019s Professor Kalyanam Shivkumar, has been awarded a prestigious Leducq International Network of Excellence Program Award of $8 million (\u00a36.3M) to set up a major new transatlantic network linking world leading researchers from the USA and Europe to develop \u2018Bioelectronics for neurocardiology diagnosis and therapeutics\u2019.
\n \n\n\n \n 9 May 2023\n \n
\n\n \n\n \n\n \n \n \n \n NDM\n \n \n\n \n\n\n
\n \n\n \n \n \nA new population-based study of 22 million people shows that autoimmune disorders now affect about one in ten individuals. The work, published in The Lancet, also highlights important socioeconomic, seasonal, and regional differences for several autoimmune disorders and provides new clues on possible causes behind these diseases.
\n \n\n\n \n 28 April 2023\n \n
\n\n \n\n \n\n \n \n \n \n Jenner\n \n \n\n \n\n\n
\n \n\n \n \n \nOxford Vaccine Group and Pandemic Sciences Institute\u2019s Professor Pollard speaks to the people who shaped the COVID-19 pandemic in his new podcast, The Oxford Colloquy.
\n \n\n\n \n 17 April 2023\n \n
\n\n \n \n \n\n \n \n \nThousands of immunosuppressed people, including patients at Oxford University Hospitals (OUH), have the chance to take part in a landmark new study investigating which people are still at the greatest risk of COVID-19 infection after vaccination.
\n \n\n\n \n 17 April 2023\n \n
\n\n \n \n \n\n \n \n \nResearchers from the University of Oxford have reported findings from a Phase 2 clinical trial investigating the efficacy of an investigational treatment against long COVID fatigue. The study (reported in Lancet eClinical Medicine) found participants given the treatment, developed by US pharmaceutical company Axcella Therapeutics, reported feeling less fatigued than those given a placebo.
\n \n\n\n \n 14 April 2023\n \n
\n\n \n \n \n\n \n \n \nThe University of Oxford-developed and Serum Institute of India PvT Ltd (SIIPL)- manufactured and scaled up R21/Matrix-MTM malaria vaccine, leveraging Novavax\u2019s adjuvant technology, has been licensed for use in Ghana by the country\u2019s Food and Drugs Authority.
\n \n\n\n \n 21 February 2023\n \n
\n\n \n \n \n\n \n \n \nHigh doses of the drug ivermectin, controversially recommended by some high-profile political and media figures during the COVID-19 pandemic, is ineffective at treating the COVID-19 virus, say University of Oxford-affiliated researchers in a study published today in eLife.
\n \n\n\n \n 21 February 2023\n \n
\n\n \n \n \n\n \n \n \nThe Coronavirus Vaccines Research and Development Roadmap is a comprehensive plan to galvanize a global effort to protect the world from this large and dangerous family of viruses.
\n \n\n\n \n 6 February 2023\n \n
\n\n \n\n \n\n \n \n \n \n Kennedy\n \n \n\n \n\n\n
\n \n\n \n \n \nIn his inaugural article in the Proceedings of the National Academy of Sciences as an NAS member (elected 2021), Prof Mike Dustin and his research team in Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences have explained how messages are passed across the immunological synapse. The research could have implications for future vaccine development and immunotherapy treatments.
\n \n\n\n \n 23 January 2023\n \n
\n\n \n \n \n\n \n \n \nCancer Research UK and the National Institute for Health and Care Research are investing over \u00a33 million across the next five years into The University of Oxford\u2019s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.
\n \n\n\n \n 19 January 2023\n \n
\n\n \n\n \n\n \n \n \n \n WIMM\n \n \n\n \n\n\n
\n \n\n \n \n \nIt was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.
\n \n\n\n \n 20 December 2022\n \n
\n\n \n \n \n\n \n \n \nA vaccine scientist from the University of Oxford recently received the prestigious Presidential Distinguished Service Award for the Irish Abroad for 2022, which recognises the contribution of members of the Irish diaspora.
\n \n\n\n \n 16 December 2022\n \n
\n\n \n \n \n\n \n \n \nNew research from the MRC Weatherall Institute of Molecular Medicine has identified a genetic marker that could be used to predict a patient\u2019s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.
\n \n\n\n \n 12 December 2022\n \n
\n\n \n \n \n\n \n \n \nAlexandra Preston, a doctoral student from MRC Human Immunology Unit (MRC Weatherall Institute of Molecular Medicine), delivered a plenary talk on 11th December at the ASH Meeting and Exposition in New Orleans, Louisiana.
\n \n\n\n \n 12 December 2022\n \n
\n\n \n \n \n\n \n \n \nIBD-associated colorectal cancers were found to occur in younger patients and have worse outcomes. Researchers call for urgent improvement of early detection methods to provide more risk-based and personalised care.
\n \n\n\n \n 2 December 2022\n \n
\n\n \n \n \n\n \n \n \nIn this long read published to coincide with International AIDS Day, we explore how an international collaboration \u2013 of which the University of Oxford is a key partner \u2013 has boosted HIV vaccine research. We thank our partners at Imperial College London for allowing us to reproduce and abridge this article.
\n \n\n